Using Tocilizumab in Sars COV-2 Dısease: Case Report

Author:

DOI : 10.29228/jamp.44395
Number of pages : 325-327

Abstract

Keywords

Abstract

Coronavirus 19 (COVID-19) may cause a cytokine release syndrome inducing the severity of the disease. Various immune modulating agents are suggested due to the lack of definitive treatment and vaccine. In this case report, we aimed to share the clinical course of a Covid 19 patient who was given tocilizumab (TCZ) for severe ARDS on the 5th day of hospitalization. Although, the patient was extubated 12 days after TCZ treatment with a rapid recovery, we believe that more cases are needed to determine the efficiency and timing of TCZ treatment.

Keywords

MAKALE İSTATİSTİKLERİ

                                

                                    

                                      
                                      
                                    

                                  

                        



               

            
 
         
                      
         

                

                    
LINKS

                    

                

            


       
            

                

                    
Share